Aerovate Therapeutics Inc

NASDAQ AVTE

Download Data

Aerovate Therapeutics Inc Working Capital Turnover Ratio for the year ending December 31, 2023: 0.00

Aerovate Therapeutics Inc Working Capital Turnover Ratio is 0.00 for the year ending December 31, 2023, a 0.00% change year over year. The working capital turnover ratio measures the efficiency of a company in utilizing its working capital to generate revenue. It is calculated by dividing the revenue by the working capital. This ratio indicates the number of times the company's working capital is converted into revenue during a specific period. A higher working capital turnover ratio suggests more efficient utilization of working capital in revenue generation.
  • Aerovate Therapeutics Inc Working Capital Turnover Ratio for the year ending December 31, 2022 was 0.00, a 0.00% change year over year.
  • Aerovate Therapeutics Inc Working Capital Turnover Ratio for the year ending December 31, 2021 was 0.00, a 0.00% change year over year.
  • Aerovate Therapeutics Inc Working Capital Turnover Ratio for the year ending December 31, 2020 was 0.00, a 0.00% change year over year.
  • Aerovate Therapeutics Inc Working Capital Turnover Ratio for the year ending December 31, 2019 was 0.00.
NASDAQ: AVTE

Aerovate Therapeutics Inc

CEO Mr. Timothy P. Noyes M.B.A.
IPO Date June 30, 2021
Location United States
Headquarters 930 Winter Street, Waltham, MA, United States, 02116
Employees 51
Sector Healthcare
Industry Biotechnology
Description

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Similar companies

ADAG

Adagene Inc

NA

NA

ACRV

Acrivon Therapeutics Inc. Common Stock

NA

NA

ANTX

AN2 Therapeutics Inc

NA

NA

ANEB

Anebulo Pharmaceuticals Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email